
MMC
Marsh & McLennan Companies Inc
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
184.326
Open
182.890
VWAP
183.71
Vol
2.38M
Mkt Cap
90.07B
Low
182.540
Amount
437.58M
EV/EBITDA(TTM)
14.34
Total Shares
492.72M
EV
107.34B
EV/OCF(TTM)
21.10
P/S(TTM)
3.44
Marsh & McLennan Companies, Inc. is a professional services company in the areas of risk, strategy and people. The Company conducts business through two segments: Risk and Insurance Services, and Consulting. Risk and Insurance Services segment includes risk management activities (risk advice, risk transfer and risk control and mitigation solutions) as well as insurance and reinsurance broking and services. It conducts business in this segment through Marsh and Guy Carpenter. Marsh is an insurance broker and risk advisor, serving companies, institutions and individuals. Guy Carpenter is a reinsurance intermediary and advisor. Consulting segment includes health, wealth and career advice, solutions and products, and specialized management, strategic, economic and brand consulting services. It conducts business in this segment through Mercer and Oliver Wyman Group. Oliver Wyman Group serves as a critical strategic, economic and brand advisor to private sector and governmental clients.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
6.54B
+7.83%
1.972
+5.47%
7.42B
+5.14%
3.239
+5.84%
7.31B
+4.87%
2.937
+7.96%
Estimates Revision
The market is revising Downward the revenue expectations for Marsh & McLennan Companies, Inc. (MMC) for FY2025, with the revenue forecasts being adjusted by -0.16% over the past three months. During the same period, the stock price has changed by -11.18%.
Revenue Estimates for FY2025
Revise Downward

-0.16%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+0.04%
In Past 3 Month
Stock Price
Go Down

-11.18%
In Past 3 Month
17 Analyst Rating
Wall Street analysts forecast MMC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MMC is 219.63 USD with a low forecast of 191.00 USD and a high forecast of 257.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
12 Hold
0 Sell
Moderate Buy
Current: 183.850
Low
191.00
Averages
219.63
High
257.00
Current: 183.850
Low
191.00
Averages
219.63
High
257.00
TD Cowen
Andrew Kligerman
Hold
downgrade
$213 -> $200
2025-11-03
Reason
TD Cowen
Andrew Kligerman
Price Target
$213 -> $200
2025-11-03
downgrade
Hold
Reason
TD Cowen analyst Andrew Kligerman lowered the firm's price target on Marsh McLennan to $200 from $213 and keeps a Hold rating on the shares. The firm updated its estimates following its Q3 results.
BofA
Neutral -> Underperform
downgrade
$243 -> $181
2025-11-03
Reason
BofA
Price Target
$243 -> $181
2025-11-03
downgrade
Neutral -> Underperform
Reason
BofA downgraded Marsh McLennan to Underperform from Neutral with a price target of $181, down from $243.
BofA
Neutral -> Underperform
downgrade
$243 -> $181
2025-11-03
Reason
BofA
Price Target
$243 -> $181
2025-11-03
downgrade
Neutral -> Underperform
Reason
As previously reported, BofA downgraded Marsh McLennan to Underperform from Neutral with a price target of $181, down from $243 based on a lower outlook for organic growth with near-term headwinds from softening property rates. The firm does not foresee any near-term catalysts supporting Marsh McLennan's organic growth and revised down its EPS forecast due to lower growth in concert with lessened margin expansion.
Goldman Sachs
Sell
to
Neutral
upgrade
$200 -> $195
2025-10-20
Reason
Goldman Sachs
Price Target
$200 -> $195
2025-10-20
upgrade
Sell
to
Neutral
Reason
Goldman Sachs upgraded Marsh McLennan to Neutral from Sell with a price target of $195, down from $200. In light of the introduction of Marsh McLennan's new Thrive program, the potential for modest organic growth tailwinds in the United States and Canada from the inclusion of the McGriff acquisition in organic growth, and the firm's 2026 organic growth estimate now being below the Economics team's expectations for U.S. nominal GDP growth, the analyst expects that its estimates and the stock's valuation are likely close to bottoming.
Roth Capital
Harry Fong
Neutral
downgrade
$230 -> $200
2025-10-20
Reason
Roth Capital
Harry Fong
Price Target
$230 -> $200
2025-10-20
downgrade
Neutral
Reason
Roth Capital analyst Harry Fong lowered the firm's price target on Marsh McLennan to $200 from $230 and keeps a Neutral rating on the shares. Marsh McLennan's Q3 underlying revenue growth was up 4%, which was likely below expectations, but in line with the firm's estimate, though the composition was different than the firm expected, the analyst tells investors in a research note.
Keefe Bruyette
Keefe Bruyette
Underperform -> Market Perform
upgrade
$209 -> $191
2025-10-17
Reason
Keefe Bruyette
Keefe Bruyette
Price Target
$209 -> $191
2025-10-17
upgrade
Underperform -> Market Perform
Reason
Keefe Bruyette upgraded Marsh McLennan to Market Perform from Underperform with a price target of $191, down from $209, following the Q3 earnings report. The shares are now reflecting persistently decelerating property and casualty pricing, the analyst tells investors in a research note. The firm believes Marsh's "Thrive" program should sustain margin improvement despite slowing pricing and fiduciary income tailwinds.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Marsh & McLennan Companies Inc (MMC.N) is 18.20, compared to its 5-year average forward P/E of 22.72. For a more detailed relative valuation and DCF analysis to assess Marsh & McLennan Companies Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Strongly Undervalued
5Y Average PE
22.72
Current PE
18.20
Overvalued PE
24.37
Undervalued PE
21.06
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
16.14
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
17.07
Undervalued EV/EBITDA
15.21
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
5.71
Current PS
183.85
Overvalued PS
23.70
Undervalued PS
-12.28
Financials
Annual
Quarterly
FY2025Q3
YoY :
+11.48%
6.35B
Total Revenue
FY2025Q3
YoY :
+9.73%
1.30B
Operating Profit
FY2025Q3
YoY :
+0.66%
757.00M
Net Income after Tax
FY2025Q3
YoY :
0.00%
1.51
EPS - Diluted
FY2025Q3
YoY :
+9.30%
2.01B
Free Cash Flow
FY2025Q3
YoY :
0.00%
100.00
Gross Profit Margin - %
FY2025Q3
YoY :
+15.88%
18.24
FCF Margin - %
FY2025Q3
YoY :
-9.70%
11.92
Net Margin - %
FY2025Q3
YoY :
-8.80%
15.75
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
4.3M
USD
1
3-6
Months
0.0
USD
0
6-9
Months
19.6M
USD
6
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
2
201.6K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
1.9M
Volume
6
0-12
Months
284.3K
Volume
7
Bought
0-3
0
0.0
Volume
Months
3-6
2
721.3K
Volume
Months
6-9
8
513.0K
Volume
Months
0-12
13
611.9K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
32.0K
USD
4
3-6
Months
0.0
USD
0
6-9
Months
199.0K
USD
4
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
32.5K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
4.3M
USD
1
3-6
Months
0.0
USD
0
6-9
Months
19.6M
USD
6
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
2
201.6K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
MMC News & Events
Events Timeline
2025-10-22 (ET)
2025-10-22
10:03:50
Marsh McLennan and Bloomberg Media Form Global Knowledge Collaboration
2025-10-16 (ET)
2025-10-16
06:32:04
Marsh McLennan to Update Stock Ticker Symbol to 'MRSH' in January 2026
2025-10-16
06:30:39
Marsh McLennan announces Q3 adjusted earnings per share of $1.85, surpassing consensus estimate of $1.78.
Sign Up For More Events
Sign Up For More Events
News
4.5
11-12NewsfilterMercer's Study Reveals US DC Plan Sponsors Will Focus on Financial Wellness, AI Integration, and Delegation by 2026
8.0
11-12NASDAQ.COMAflac's Dividend Increases for the 43rd Consecutive Time, Outpacing Competitors
6.0
11-03BenzingaCharter Communications Analyst Changes Stance; Check Out the Top 5 Downgrades for Monday
Sign Up For More News
People Also Watch

KLAC
KLA Corp
1161.720
USD
-3.11%

CEG
Constellation Energy Corp
335.740
USD
-5.16%

BKNG
Booking Holdings Inc
5075.610
USD
-1.93%

SPGI
S&P Global Inc
502.960
USD
+1.44%

BLK
BlackRock Inc
1069.650
USD
-2.22%

RTX
RTX Corp
173.960
USD
-2.10%

MELI
MercadoLibre Inc
2031.050
USD
-3.46%

DHR
Danaher Corp
221.200
USD
+0.82%

HDB
HDFC Bank Ltd
36.270
USD
-0.58%

BX
Blackstone Inc
139.530
USD
-3.35%
FAQ
What is Marsh & McLennan Companies Inc (MMC) stock price today?
The current price of MMC is 183.85 USD — it has increased 0.58 % in the last trading day.





